My bookmarksSign up free
Source

Commission Implementing Decision (EU) 2025/439 of 28 February 2025 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council (notified under document C(2025) 1244)

Commission Implementing Decision (EU) 2025/439 of 28 February 2025 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council (notified under document C(2025) 1244)

Implementing Decision (EU) 2025/439 · Decision · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The watch list of substances for Union-wide monitoring referred to in Article 8b of Directive 2008/105/EC is set out in the Annex to this Decision.

Supplementary provisions

Watch list of substances for Union-wide monitoring as set out in Article 8b of Directive 2008/105/EC

ANNEXSupplementary provisions

Open ↗

ANNEX Watch list of substances for Union-wide monitoring as set out in Article 8b of Directive 2008/105/EC Name of substance/group of substances Chemical Abstracts Service (CAS) number European Community (EC) number  ( 1 ) Indicative analytical method  ( 2 ) ,  ( 3 ) Maximum acceptable method quantification limit (ng/l) Fipronil 120068-37-3 424-610-5 SPE-HPLC-MS/MS 0,77 Clindamycin 18323-44-9 242-209-1 SPE-LC-MS/MS 44 Ofloxacin 82419-36-1 680-263-1 SPE-UHPLC-MS/MS 26 Metformin and Guanylurea  ( 4 ) 657-24-9 141-83-3 211-517-8 205-504-6 SPE-LC-MS/MS 156 000 100 000 Sunscreen agents  ( 5 ) Butyl methoxydibenzoyl-methane Octocrylene Benzophenone-3 Octisalate (2-ethylhexyl salicylate) 70356-09-1 6197-30-4 131-57-7 118-60-5 274-581-6 228-250-8 205-031-5 204-263-4 SPE-LC-ESI-MS/MS 3 000 266 670 168 N-1,3-Dimethylbutyl-N’-phenyl-p-phenylenediamine (6PPD) and 6PPD-quinone  ( 6 ) 793-24-8 2754428-18-5 212-344-0 893-269-6 SPE-LC-MS/MS 370 Abamectin  ( 7 ) Avermectin B1a and Avermectin B1b 71751-41-2 65195-55-3 65195-56-4 265-610-3 265-611-9 SPE-LC-MS/MS 1 Azole compounds  ( 8 ) Bromuconazole Climbazole Cyazofamid Difenoconazole Epoxiconazole Itraconazole Ketoconazole Mefentrifluconazole Propiconazole Triticonazole 116255-48-2 38083-17-9 120116-88-3 119446-68-3 133855-98-8 84625-61-6 65277-42-1 1417782-03-6 60207-90-1 131983-72-7 408-060-3 253-775-4 601-671-8 601-613-1 406-850-2 617-596-9 265-667-4 822-682-6 262-104-4 603-543-7 SPE-LC-MS/MS 15 110 130 360 180 8 50 1 600 1 000 1 000 Etoxazole 153233-91-1 604-891-2 SPE-GC-MS/MS 0,4 Fluoxetine 54910-89-3 611-209-7 SPE-LC-QTOF-HRMS 12 Propranolol 525-66-6 208-378-0 SPE-LC-MS/MS 20 Oxytetracycline and Tetracycline  ( 9 ) 79-57-2 60-54-8 201-212-8 200-481-9 SPE-LC-MS/MS 500 90 ( 1 )   Not available for all substances ( 2 )   All substances shall be monitored in whole water samples. ( 3 )   Extraction methods: SPE – solid-phase extraction Analytical methods: HPLC-MS/MS– High-performance liquid chromatography (tandem) triple quadrupole mass spectrometry LC-MS/MS – Liquid chromatography (tandem) triple quadrupole mass spectrometry LC-ESI-MS/MS – Liquid chromatography (tandem) triple quadrupole mass spectrometry with positive electrospray ionisation LC-QTOF-HRMS – Liquid chromatography quadrupole time-of-flight high-resolution mass spectrometry UHPLC-MS/MS – Ultra-high-performance liquid chromatography (tandem) triple quadrupole mass spectrometry ( 4 )   Metformin and guanylurea shall be analysed together in the same samples but reported as individual concentrations. ( 5 )   The sunscreen agents shall be analysed together in the same samples but reported as individual concentrations. ( 6 )   6PPD and 6PPD-quinone shall be analysed together in the same samples but reported as individual concentrations ( 7 )   The two major components of abamectin (B1a and B1b) shall be analysed together in the same samples and reported as a sum concentration. ( 8 )   The azole compounds shall be analysed together in the same samples but reported as individual concentrations. ( 9 )   Oxytetracycline and tetracycline shall be analysed together in the same samples but reported as individual concentrations.

Other acts of the same type
Council Decision (EU) 2022/2102 of 13 October 2022 on the position to be taken on behalf of the European Union within the Council of Members of the International Olive Council as regards the conditions for the accession of the Government of the Republic of Azerbaijan to the International Agreement on Olive Oil and Table Olives, 2015Council Decision (EU) 2022/2103 of 13 October 2022 on the position to be taken on behalf of the European Union within the Council of Members of the International Olive Council as regards the elimination of the category ordinary virgin olive oil from Annex B of the International Agreement on Olive Oil and Table Olives, 2015Commission Implementing Decision (EU) 2022/1933 of 12 October 2022 amending Council Directive 2008/90/EC as regards the extension of the derogation relating to import conditions for fruit plant propagating material and fruit plants intended for fruit production from third countries (notified under document C(2022) 7148)Commission Implementing Decision (EU) 2022/1954 of 12 October 2022 on harmonised standards for recreational craft and personal watercraft drafted in support of Directive 2013/53/EU of the European Parliament and of the Council (Text with EEA relevance)Commission Decision (EU) 2022/1928 of 11 October 2022 confirming the participation of Ireland in Regulation (EU) 2022/585 of the European Parliament and of the Council amending Regulations (EU) No 514/2014 laying down general provisions on the Asylum, Migration and Integration Fund and on the instrument for financial support for police cooperation, preventing and combating crime, and crisis management, (EU) No 516/2014 establishing the Asylum, Migration and Integration Fund and (EU) 2021/1147 establishing the Asylum, Migration and Integration FundCommission Implementing Decision (EU) 2022/1973 of 11 October 2022 on the recognition of the United Kingdom pursuant to Directive (EU) 2022/993 as regards the system for training and certification of seafarers (notified under document C(2022) 7109) (Text with EEA relevance)Commission Implementing Decision (EU) 2022/2110 of 11 October 2022 establishing the best available techniques (BAT) conclusions, under Directive 2010/75/EU of the European Parliament and of the Council on industrial emissions, for the ferrous metals processing industry (notified under document C(2022) 7054) (Text with EEA relevance)Decision (EU) 2022/1981 of the European Central Bank of 10 October 2022 on the use of services of the European System of Central Banks by competent authorities (ECB/2022/33)Decision (EU) 2022/1982 of the European Central Bank of 10 October 2022 on the use of services of the European System of Central Banks by competent authorities and by cooperating authorities, and amending Decision ECB/2013/1 (ECB/2022/34)Commission Implementing Decision (EU) 2022/1953 of 7 October 2022 on greenhouse gas emissions covered by Decision No 406/2009/EC of the European Parliament and of the Council for the year 2020 for each Member StateCouncil Implementing Decision (CFSP) 2022/1902 of 6 October 2022 implementing Decision 2014/932/CFSP concerning restrictive measures in view of the situation in YemenCouncil Decision (CFSP) 2022/1907 of 6 October 2022 amending Decision 2014/145/CFSP concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next